Almac Group
Almac is a pharmaceutical service provider with over 30 years experience. The company provides a range of services including research and development, pharmaceutical testing and clinical trials as well as the commercialisation of pharmaceutical products. The company has experience in biomarker discovery and development through its partners and through internal R&D.
Almac provides comprehensive support from drug discovery through to scale-up and launch of new drugs. Pharmaceutical development includes pre-formulation of drugs, testing and taking them to market. The company has three chemical trial sites globally, with one in Northern Ireland situated at Craigavon.
The company also specialises in the design and manufacture of drug packaging including blistering, bottling and walleting/carding of pharmaceuticals.
Financial Data
-
30th Sep 20 Source: CRO
- €743.8 million turnover
-
€69.8 million
profit - 5,466 employees
-
30th Sep 19 Source: CRO
- €742.8 million turnover
-
€55.8 million
profit - 5,150 employees
- 12 more years available »
Ranking
By Turnover
(€743.8 million)- 120th in Top Companies
- 18th in Health
By Employees
(5,466)- 41st in Top Companies
- 7th in Health
-
- 5,466
- €743.8 million
Employees
- Alan Armstrong CEO/Managing Director
Latest News
- May 24 Harsh winter may compel Europe to ration gas, warns International Energy Agency
- May 24 Hungary and Poland hold up EU decisions on oil and corporate tax
- May 24 Over 700 objections lodged against €466m Dundrum apartment ‘concrete jungle’
- May 24 Stripe unveils new third party app marketplace
- May 24 Shares in UK energy companies slide over windfall tax fears